In this study, we explored the role of the GLP1 system in the compensatory upregulation of insulin secretion during conditions of insulin resistance in mice and examined the influence of GPR119 activation, which during recent years have been explored as a potential target for the treatment of type 2 diabetes (16). The gene discussed is INS; the disease is Insulin resistance.